Jasmonate ZIM Domain Protein () Gene Increases Resistance to in Tomato.

Plants (Basel)

Key Laboratory at the Universities of Xinjiang Uygur Autonomous Region for Oasis Agricultural Pest Management and Plant Protection Resource Utilization, Agriculture College, Shihezi University, Shihezi 832003, China.

Published: May 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Pers. is a holoparasitic plant that severely reduces tomato ( L.) production in China. However, there is a lack of effective control methods and few known sources of genetic resistance. In this study, we focused on key genes in the family, comparing the family in (L. Heynh.) to the tomato genome. After identifying the family members in , we performed chromosomal localization and linear analysis with phylogenetic relationship analysis of the family. We also analyzed the gene structure of the gene family members in tomato and the homology of the genes among the different species to study their relatedness. The key genes for resistance were identified using VIGS (virus-induced gene silencing), and the parasitization rate of silenced tomato plants against increased by 47.23-91.13%. The genes were localized in the nucleus by subcellular localization. Heterologous overexpression in showed that the key gene had a strong effect on the parasitization process of , and the overexpression of the key gene reduced the parasitization rate of 1.69-fold. Finally, it was found that the gene can positively regulate the hormone content in tomato plants and affect plant growth and development, further elucidating the function of this gene.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11174562PMC
http://dx.doi.org/10.3390/plants13111493DOI Listing

Publication Analysis

Top Keywords

gene
8
key genes
8
family members
8
parasitization rate
8
tomato plants
8
overexpression key
8
key gene
8
tomato
6
family
5
jasmonate zim
4

Similar Publications

Background: Omeprazole, a widely used proton pump inhibitor, has been associated with rare but serious adverse events such as myopathy. Previous research suggests that concurrent use of omeprazole with fluconazole, a potent cytochrome P450 (CYP) 2C19/3A4 inhibitor, may increase the risk of myopathy. However, the contribution of genetic polymorphisms in CYP enzymes remains unclear.

View Article and Find Full Text PDF

Purpose: Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) is a rare cancer susceptibility syndrome exclusively attributable to pathogenic variants in FH (HGNC:3700). This paper quantitatively weights the phenotypic context (PP4/PS4) of such very rare variants in FH.

Methods: We collated clinical diagnostic testing data on germline FH variants from 387 individuals with HLRCC and 1,780 individuals with renal cancer, and compared the frequency of 'very rare' variants in each phenotypic cohort against 562,295 population controls.

View Article and Find Full Text PDF

CRISPR homing gene drive is a disruptive biotechnology developed over the past decade with potential applications in public health, agriculture, and conservation biology. This technology relies on an autonomous selfish genetic element able to spread in natural populations through the release of gene drive individuals. However, it has not yet been deployed in the wild.

View Article and Find Full Text PDF

Background: C-C motif chemokine ligand 3 (CCL3) is a crucial chemokine that plays a fundamental role in the immune microenvironment and is closely linked to the development of various cancers. Despite its importance, there is limited research regarding the expression and function of CCL3 in nasopharyngeal carcinoma (NPC). Therefore, this study seeks to examine the expression of CCL3 and assess its clinical significance in NPC using bioinformatics analysis and experiments.

View Article and Find Full Text PDF

Background: Prostate cancer is one of the most common malignancies in males worldwide. Serum prostate-specific antigen is a frequently employed biomarker in the diagnosis and risk stratification of prostate cancer; however, it is known for its low predictive accuracy for disease progression. New prognostic biomarkers are needed to distinguish aggressive prostate cancer from low-risk disease.

View Article and Find Full Text PDF